Related Experiment Videos
Score tests for familial correlation in genotyped-proband designs
R J Carroll1, M H Gail, J Benichou
1Department of Statistics, Texas A&M University, College Station, Texas 77843-3143, USA. carroll@stat.tamu.edu
Genetic Epidemiology
|May 8, 2000
Summary
This study introduces a score test to evaluate conditional independence in genetic studies with missing genotype data. The method simplifies analysis and is applied to breast cancer penetrance in BRCA1/BRCA2 mutation carriers.
Area of Science:
- Genetics
- Epidemiology
- Statistical genetics
Background:
- The genotyped-proband design involves observing a proband's phenotype and genotype, then relatives' phenotypes, but not their genotypes.
- Existing analyses assume conditional independence of phenotypes given genotypes, an assumption that may not always hold.
- Developing tests for conditional independence is crucial for robust genetic analyses.
Purpose of the Study:
- To develop a score test for the conditional independence assumption in genetic studies.
- To address models with covariates or partial observation of relatives' genotypes.
- To provide a robust and simple analytical approach for missing covariate data.
Main Methods:
- The study frames the problem as score testing in the presence of missing covariates.
- A natural conditional likelihood is used to develop the score test.
- The proposed method avoids the need to specify covariate distributions, enhancing model-robustness.
Main Results:
- A simple score test is derived for conditional independence.
- The method is applicable to complex models including covariates and partially observed genotypes.
- The approach is demonstrated using data on breast cancer penetrance for BRCA1 and BRCA2 mutations.
Conclusions:
- The developed score test offers a robust and straightforward method for assessing conditional independence in genetic epidemiology.
- This approach is valuable for studies with missing genotype data, improving analytical accuracy.
- The methods are practically applied to understanding breast cancer risk associated with BRCA mutations in specific populations.